Can-Fite BioPharma American Depositary Shares
CANF
6 hedge funds and large institutions have $2.07M invested in Can-Fite BioPharma American Depositary Shares in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
8% less capital invested
Capital invested by funds: $2.26M → $2.07M (-$189K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$35K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Advisor Group
Phoenix,
Arizona
|
-$10K |
| 2 |
MC
Menta Capital
San Francisco,
California
|
-$7.01K |
| 3 |
Morgan Stanley
New York
|
-$7.01K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$5K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $1.9M | – | – | – |
|
|
MC
2
Menta Capital
San Francisco,
California
| $100K | -$7.01K | -1 | -7% |
|
|
3
Citadel Advisors
Miami,
Florida
| $34K | +$35K | +5 | New |
|
|
VKH
4
Virtu KCG Holdings
New York
| $29K | +$28K | +4 | New |
|
|
5
Morgan Stanley
New York
| $6K | -$7.01K | -1 | -50% |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | +$7.01K | +1 | New |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| – | -$10K | -1 | Closed |
|
|
8
Group One Trading
Chicago,
Illinois
| – | -$5K | -1 | Closed |
|
|
IA
9
IFP Advisors
Tampa,
Florida
| – | -$3K | – | – |
|
CANF Hedge Fund Activity: Q4 2016 in Review
6 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2016, worth a combined $2.07M — down 8.4% from $2.26M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CANF positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $35K. The largest seller was Advisor Group, exiting entirely with an estimated $10K sold.
- 6 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2016, up from 5 in Q3 2016.
- Funds reported $2.07M of Can-Fite BioPharma American Depositary Shares stock for Q4 2016, down 8.4% quarter-over-quarter.
- 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2016 and 2 closed out, a net change of +1 holder.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2016 was Citadel Advisors, an estimated $35K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2016 was Advisor Group, an estimated $10K sold.
Based on aggregated 13F filings for Q4 2016.